The role of diabetes mellitus in patients with bloodstream infections

Swiss Medical Weekly

Volumn 138, Issue 35-36, 2008, Pages 512-519

  Stoeckle, M ^a   Kaech, C ^a   Trampuz, A ^a   Zimmerli, Werner ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Kantonsspital Liestal Medizinische Klinik   (Switzerland)

Author keywords

Bloodstream infection; Diabetes mellitus; Klebsiella pneumoniae; Outcome; Sepsis

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CATHETER INFECTION; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISSEMINATED INTRAVASCULAR CLOTTING; ESCHERICHIA COLI; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; INFECTION RISK; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; SEPSIS; UNIVARIATE ANALYSIS; URINARY TRACT INFECTION;

EID: 51549094943     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341:1906-12.
2. Bertoni AG, Saydah S, Brancati FL. Diabetes and the risk of infection-related mortality in the U.S. Diabetes Care. 2001;24:1044-9.
3. Cooper G, Platt R. Staphylococcus aureus bacteremia in diabetic patients. Endocarditis and mortality. Am J Med. 1982;73:658-62.
4. Hill PC, Birch M, Chambers S, Drinkovic D, Ellis-Pegler RB, Everts R, et al. Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality. Intern Med J. 2001;31:97-103.
5. Factor SH, Levine OS, Schwartz B, Harrison LH, Farley MM, McGeer A, Schuchat A. Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis. 2003;9:970-7.
6. Jackson LA, Hilsdon R, Farley MM, Harrison LH, Reingold AL, Plikaytis BD, et al. Risk factors for group B streptococcal disease in adults. Ann Intern Med. 1995;123:415-20.
7. Nuorti JP, Butler JC, Farley MM, Harrison LH, McGeer A, Kolczak MS, Breiman RF. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med. 2000;342:681-9.
8. Trampuz A, Widmer AF, Fluckiger U, Haenggi M, Frei R, Zimmerli W. Changes in the epidemiology of pneumococcal bacteremia in a Swiss University Hospital during a 15-year-period, 1986-2000. Mayo Clin Proc. 2004;79:604-12.
9. Kaech C, Elzi L, Sendi P, Frei R, Laifer G, Bassetti S, Fluckiger U. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Clin Microbiol Infect. 2006;12:345-52.
10. Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AI, Rutten GE. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005;41:281-8.
11. Calvet HM, Yoshikawa TT. Infections in diabetes. Infect Dis Clin North Am. 2001;15:407-21.
12. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26:259-65.
13. Valerius NH, Eff C, Hansen NE, Karle H, Nerup J, Soeberg B, Sorensen SF. Neutrophil and lymphocyte function in patients with diabetes mellitus. Acta Med Scand. 1982;211:463-7.
14. Alba-Loureiro TC, Munhoz CD, Martins JO, Cerchiaro GA, Scavone C, Curi R, Sannomiya P. Neutrophil function and metabolism in individuals with diabetes mellitus. Braz J Med Biol Res. 2007;40:1037-44.
15. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H. Infection and diabetes: the case for glucose control. Am J Med. 1982;72:439-50.
16. Moutschen MP, Scheen AJ, Lefebvre PJ. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab. 1992;18:187-201.
17. McMahon MM, Bistrian BR. Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am. 1995;9:1-9.
18. Lipsky BA, Pecoraro RE, Chen MS, Koepsell TD. Factors affecting staphylococcal colonization among NlDDM outpatients. Diabetes Care. 1987;10:483-6.
19. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med. 2001;344:11-6.
20. Chi CY, Wong WW, Fung CP, Yu KW, Liu CY. Epidemiology of community-acquired Staphylococcus aureus bacteremia. J Microbiol Immunol Infect. 2004;37:16-23.
21. Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Schonheyder HC, Sorensen HT. Diabetes mellitus as a risk and prognostic factor for community-acquired bacteremia due to enterobacteria: a 10-year, population-based study among adults. Clin Infect Dis. 2005;40:628-31.
22. Thomsen RW, Jepsen P, Sorensen HT. Diabetes mellitus and pyogenic liver abscess: risk and prognosis. Clin Infect Dis. 2007;44:1194-201.
23. Chen SC, Lee YT, Lai KC, Cheng KS, Jeng LB, Wu WY, et al. Risk factors for developing metastatic infection from pyogenic liver abscesses. Swiss Med Wkly. 2006;136:119-26.
24. Horvath K, Jeitler K, Berghold A, Ebrahim SH, Gratzer TW, Plank J, et al. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2007:CD005613.
25. Krentz AJ, Bailey CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs. 2005;65:385-411.
26. Hoogwerf BJ. Postoperative management of the diabetic patient. Med Clin North Am. 2001;85:1213-28.
27. Bryan CS, Reynolds KL, Metzger WT. Bacteremia in diabetic patients: comparison of incidence and mortality with nondiabetic patients. Diabetes Care. 1985;8:244-9.
28. MacFarlane IA, Brown RM, Smyth RW, Burdon DW, FitzGerald MG. Bacteraemia in diabetics. J Infect. 1986;12:213-9.
29. Carton JA, Maradona JA, Nuno FJ, Fernandez-Alvarez R, Perez-Gonzalez F, Asensi V. Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients. Eur J Med. 1992;1:281-7.
30. Leibovici L, Samra Z, Konisberger H, Kalter-Leibovici O, Pitlik SD, Drucker M. Bacteremia in adult diabetic patients. Diabetes Care. 1991;14:89-94.
31. Laffer RR, Frei R, Widmer AF. Epidemiology of septicemias in a university hospital over 5 years. Schweiz Med Wochenschr. 2000;130:1471-8.
32. Hansen DS, Gottschau A, Kolmos HJ. Epidemiology of Klebsiella bacteraemia: a case control study using Escherichia coli bacteraemia as control. J Hosp Infect. 1998;38:119-32.
33. Wang JH, Liu YC, Lee SS, Yen MY, Chen YS, Wang JH, et al. Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis. 1998;26:1434-8.
34. Geerlings SE, Meiland R, van Lith EC, Brouwer EC, Gaastra W, Hoepelman AI. Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects. Diabetes Care. 2002;25:1405-9.
35. Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, Relier LB. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997;24:584-602.
36. Uzun O, Akalin HE, Hayran M, Unal S. Factors influencing prognosis in bacteremia due to gram-negative organisms: evaluation of 448 episodes in a Turkish university hospital. Clin Infect Dis. 1992;15:866-73.
37. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-67.